Abstract
Loss of Fanconi anemia (FA) proteins activity by recessive inherited mutations in one of the FA genes leads to a disease characterized by bone marrow failure, myeloid leukemia and DNA damage hypersensitivity. The aim of this work was to improve our understanding of the FA syndrome defining the transcription profile of the FA complementation group C (FANCC)-deficient cells in comparison to their ectopically corrected counterpart using oligonucleotide microarrays. In this way, 49 RNAs have been isolated, which showed a consistent differential pattern of expression among FANCC mutated and corrected cells. The observed specific changes in gene expression suggest that FANCC regulates specifically myeloid differentiation and unmasks a previously unsuspected anti-inflammatory role for the FA proteins. In spite of the DNA damage hypersensitivity of the syndrome, no gene coding for a protein directly involved in DNA repair/damage response was found to be deregulated in our analysis. This observation suggests that FANCC does not directly control genes involved in DNA repair at the transcriptional level, but does not exclude a regulation at the translational or post-translational level, or by protein/protein interactions. The potential role of the differentially expressed genes in FA phenotype as well as a functional- and cellular-based clustering of the identified genes are presented and discussed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahmad SI, Hanaoka F and Kirk SH . (2002). Bioessays, 24, 439–448.
Alter BP . (1996). Am. J. Hematol., 53, 99–110.
Bedford FK, Ashworth A, Enver T and Wiedemann LM . (1993). Nucleic Acids Res., 21, 1245–1249.
Benezra M, Chevallier N, Morrison DJ, MacLachlan TK, El-Deiry WS and Licht JD . (2003). J. Biol. Chem., 278, 26333–26341.
Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN and Golub TR . (2000). Proc. Natl. Acad. Sci. USA, 97, 3260–3265.
Curtis DJ, Jane SM, Hilton DJ, Dougherty L, Bodine DM and Begley CG . (2000). Exp. Hematol., 28, 1250–1259.
D'Andrea AD and Grompe M . (2003). Nat. Rev. Cancer, 3, 23–34.
Dolis D, Moreau C, Zachowski A and Devaux PF . (1997). Biophys. Chem., 68, 221–231.
Folias A, Matkovic M, Bruun D, Reid S, Hejna J, Grompe M, D'Andrea A and Moses R . (2002). Hum. Mol. Genet., 11, 2591–2597.
Grompe M and D'Andrea A . (2001). Hum. Mol. Genet., 10, 2253–2259.
Hanada T and Yoshimura A . (2002). Cytokine Growth Factor Rev., 13, 413–421.
Hansen GM and Justice MJ . (1999). Oncogene, 18, 6531–6539.
Hashimoto S, Suzuki T, Dong HY, Nagai S, Yamazaki N and Matsushima K . (1999). Blood, 94, 845–852.
Hoatlin ME, Zhi Y, Ball H, Silvey K, Melnick A, Stone S, Arai S, Hawe N, Owen G, Zelent A and Licht JD . (1999). Blood, 94, 3737–3747.
Hromas R, Radich J and Collins S . (1993). Biochem. Biophys. Res. Commun., 195, 976–983.
Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA and Sartor RB . (1999). J. Immunol., 163, 3474–3483.
Joenje H and Patel KJ . (2001). Nat. Rev. Genet., 2, 446–457.
Karanu FN, Murdoch B, Gallacher L, Wu DM, Koremoto M, Sakano S and Bhatia M . (2000). J. Exp. Med., 192, 1365–1372.
Lehnert M . (1996). Eur. J. Cancer, 32A, 912–920.
Li PX, Wong J, Ayed A, Ngo D, Brade AM, Arrowsmith C, Austin RC and Klamut HJ . (2000). J. Biol. Chem., 275, 20127–20135.
Li Q and Verma IM . (2002). Nat. Rev. Immunol., 2, 725–734.
Li Y and Youssoufian H . (1997). J. Clin. Invest., 100, 2873–2880.
Lindsell CE, Shawber CJ, Boulter J and Weinmaster G . (1995). Cell, 80, 909–917.
Macdonald D, Aguiar RC, Mason PJ, Goldman JM and Cross NC . (1995). Leukemia, 9, 1628–1630.
Manfioletti G, Gattei V, Buratti E, Rustighi A, De Iuliis A, Aldinucci D, Goodwin GH and Pinto A . (1995). Blood, 85, 1237–1245.
Mills JC, Roth KA, Cagan RL and Gordon JI . (2001). Nat. Cell. Biol., 3, E175–E178.
Orkin SH . (2000). Nat. Rev. Genet., 1, 57–64.
Otsuki T, Furukawa Y, Ikeda K, Endo H, Yamashita T, Shinohara A, Iwamatsu A, Ozawa K and Liu JM . (2001). Hum. Mol. Genet., 10, 2651–2660.
Pallis M and Russell N . (2000). Blood, 95, 2897–2904.
Pang Q, Keeble W, Christianson TA, Faulkner GR and Bagby GC . (2001a). EMBO J., 20, 4478–4489.
Pang Q, Keeble W, Diaz J, Christianson TA, Fagerlie S, Rathbun K, Faulkner GR, O'Dwyer M and Bagby Jr. GC . (2001b). Blood, 97, 1644–1652.
Popovici C, Adelaide J, Ollendorff V, Chaffanet M, Guasch G, Jacrot M, Leroux D, Birnbaum D and Pebusque MJ . (1998). Proc. Natl. Acad. Sci. USA, 95, 5712–5717.
Popovici C, Zhang B, Gregoire MJ, Jonveaux P, Lafage-Pochitaloff M, Birnbaum D and Pebusque MJ . (1999). Blood, 93, 1381–1389.
Reber M and Cereghini S . (2001). Mech. Dev., 100, 75–78.
Rosselli F, Sanceau J, Gluckman E, Wietzerbin J and Moustacchi E . (1994). Blood, 83, 1216–1225.
Rousset S, Nocentini S, Rouillard D, Baroche C and Moustacchi E . (2002). Photochem. Photobiol., 75, 159–166.
Ruppitsch W, Meisslitzer C, Weirich-Schwaiger H, Klocker H, Scheidereit C, Schweiger M and Hirsch-Kauffmann M . (1997). Hum. Genet., 99, 710–719.
Schreuder H, Tardif C, Trump-Kallmeyer S, Soffientini A, Sarubbi E, Akeson A, Bowlin T, Yanofsky S and Barrett RW . (1997). Nature, 386, 194–200.
Schultz JC and Shahidi NT . (1993). Am. J. Hematol., 42, 196–201.
Sullivan DM, Chung DC, Anglade E, Nussenblatt RB and Csaky KG . (1996). Invest. Ophthalmol. Vis. Sci., 37, 766–774.
Strathdee CA, Gavish H, Shannon WR and Buchwald M . (1992). Nature, 356, 763–767.
Sun Z and Hopkins N . (2001). Genes. Dev., 15, 3217–3229.
Tohda S and Nara N . (2001). Leukemia Lymphoma, 42, 467–472.
Tronche F and Yaniv M . (1992). Bioessays, 14, 579–587.
Walker L, Carlson A, Tan-Pertel HT, Weinmaster G and Gasson J . (2001). Stem. Cells, 19, 543–552.
Ward PA and Lentsch AB . (2002). Mol. Cell. Biochem., 234–235, 225–228.
Walsh CE, Nienhuis AW, Samulski RJ, Brown MG, Miller JL, Young NS and Liu JM . (1994). J. Clin. Invest., 94, 1440–1448.
Xie Y, de Winter JP, Waisfisz Q, Nieuwint AW, Scheper RJ, Arwert F, Hoatlin ME, Ossenkoppele GJ, Schuurhuis GJ and Joenje H . (2000). Br. J. Haematology, 111, 1057–1064.
Zhang F, Altorki NK, Mestre JR, Subbaramaiah K and Dannenberg AJ . (1999). Carcinogenesis, 20, 445–451.
Acknowledgements
We thank Dr C Guillouf for helpful discussion, and C Wanherdrick and R Culerrier for excellent technical assistance. This work was supported by Grant from the Association pour la Recherche contre le Cancer (ARC), Fondation de France, GEFLUC and the Ministere de la Recherche, France. R Zanier was a fellow of CNR, Italy.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zanier, R., Briot, D., Villard, JA. et al. Fanconi anemia C gene product regulates expression of genes involved in differentiation and inflammation. Oncogene 23, 5004–5013 (2004). https://doi.org/10.1038/sj.onc.1207677
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207677
Keywords
This article is cited by
-
Fanca deficiency is associated with alterations in osteoclastogenesis that are rescued by TNFα
Cell & Bioscience (2023)
-
FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations
Oncogene (2023)
-
Polyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution
Experimental Hematology & Oncology (2022)
-
Beyond DNA repair and chromosome instability—Fanconi anaemia as a cellular senescence-associated syndrome
Cell Death & Differentiation (2021)
-
Fancd2 in vivo interaction network reveals a non-canonical role in mitochondrial function
Scientific Reports (2017)